US-based pharmaceutical big Pfizer Inc. shares surged greater than 7% through the intraday session on Wall Road after United States President Donald Trump introduced that the corporate plans to cut back drug costs in the US.
Trump on Tuesday mentioned that Pfizer will lower the worth of all prescribed drugs within the Medicaid program for low-income US residents and promote new prescribed drugs at a “most favoured nation” worth in trade for tariff reduction.
US President Donald Trump additionally introduced that he expects different drugmakers to additionally comply with Pfizer’s lead and lower costs for medication offered to Americans.
“The US is completed subsidising the healthcare of the remainder of the world,” mentioned Trump, chatting with the media together with Pfizer CEO Albert Bourla and different executives.
Trump earlier introduced a 100% conditional tariff on pharmaceutical imports into the US, efficient Wednesday, 1 October 2025.
Pfizer Share Worth Pattern
Pfizer Inc. share worth closed 6.69% increased at $25.45 after Tuesday’s Wall Road session, in comparison with $23.85 on the earlier market shut. The corporate’s inventory jumped greater than 7% throughout Tuesday’s intraday session to its excessive degree of $25.63.
Shares of the pharma firm misplaced 26% within the final 5 years and are buying and selling 11.96% decrease within the final one-year interval. On a year-to-date (YTD) foundation, Pfizer shares are down 4.25% in 2025.
Nonetheless, Pfizer inventory has given US market traders greater than 2% returns on their funding within the final one-month interval, and the shares are buying and selling over 5% within the final 5 market classes on Wall Road.
In line with the info collected from MarketWatch, the corporate shares hit their 52-week excessive degree at $30.43, whereas the 52-week low degree stood at $20.92. The corporate’s market capitalisation (M-Cap) stood at $135.6 billion as of the inventory market session on Tuesday, 30 September 2025.
As per the after-hours market session on Wall Road, the shares of the pharma main had been buying and selling 0.27% decrease at $25.41, in comparison with the market shut at $25.48.
Learn all tales by Anubhav Mukherjee
Disclaimer: This story is for academic functions solely. The views and proposals above are these of particular person analysts or broking corporations, not Mint. We advise traders to examine with licensed consultants earlier than making any funding choices.
